II
ROIV icon

Inspire Investing’s Roivant Sciences ROIV Stock Holding History

Inspire Investing’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Buy
74,085
+2,849
+4% +$84.2K 0.11% 213
2026
Q1 		$1.97M Buy
71,236
+55,990
+367% +$1.44M 0.12% 205
2025
Q4 		$331K Sell
15,246
-5,115
-25% -$101K 0.03% 745
2025
Q3 		$308K Sell
20,361
-4,535
-18% -$56.1K 0.03% 791
2025
Q2 		$281K Sell
24,896
-5,086
-17% -$55.1K 0.03% 775
2025
Q1 		$303K Buy
+29,982
New +$324K 0.04% 787

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Inspire Investing's ROIV Position: Q2 2026 in Review

Inspire Investing increased its Roivant Sciences (ROIV) stake by 4% in Q2 2026, buying an estimated $84.2K and bringing the position to 74,085 shares worth $2.62M. The position accounts for 0.11% of the portfolio, ranked #213.

Inspire Investing first reported a position in ROIV in Q1 2025 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Inspire Investing held 74,085 shares of Roivant Sciences worth $2.62M as of Q2 2026.
  • Inspire Investing bought 2,849 Roivant Sciences shares in Q2 2026, an estimated $84.2K.
  • Roivant Sciences made up 0.11% of Inspire Investing's portfolio in Q2 2026, its #213 holding.
  • Inspire Investing first reported a position in Roivant Sciences in Q1 2025 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.